BusinessAbbVie Raises Full-Year Guidance After $17.4 Billion in Third-Quarter RevenueBy Helena WardOct 30, 2026, 2:31 PM UTC
InvestingAbbVie Raises Quarterly Dividend to $1.82 Per Share for February PaymentBy Celia RowanOct 30, 2026, 2:10 PM UTC
BusinessAnalysts Forecast AbbVie Q3 Earnings of $3.77 Per Share Ahead of ReportBy Helena WardOct 30, 2026, 12:36 AM UTC
HealthAbbVie Reports 40.5% Crohn’s Remission With ABBV-466 at Week 24By Naomi CalderOct 19, 2026, 2:04 PM UTC
HealthAbbVie Reports 86.6% Crohn’s Remission at Week 144 in IBD StudyBy Naomi CalderOct 17, 2026, 10:14 AM UTC
